NDCFind

Strensiq 25682-0019

Generic: Asfotase Alfa

Product NDC

25682-0019
Manufacturer
Alexion Pharmaceuticals, Inc.
Dosage Form
Solution
Route
Subcutaneous
Product Type
Human Prescription Drug
Marketing Start
October 23, 2015
Listing Expires
December 31, 2026
Application
BLA125513
StockMeds — pharmacy-to-pharmacy marketplace

Need to source Strensiq? P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

IngredientStrength
Asfotase Alfa80 mg/.8mL

Drug Class

Tissue-nonspecific Alkaline Phosphatase [EPC]Alkaline Phosphatase [CS]Tissue-nonspecific Alkaline Phosphatase [EPC]

Packaging Options(1)

12 VIAL in 1 CARTON (25682-019-12) / .8 mL in 1 VIAL (25682-019-01)